A trial for confirming the accuracy of PanTum test for solid tumor detection.
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2022/09/045374
- Lead Sponsor
- Millennium Oncology India Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Written informed consent.
-Consent to undergo PET/CT examination in specific study centers in case of a positive index test result of a healthy subject.
-Healthy controls: Age 30-75 years.
-Sick population: Histopathology/Cytology proven diagnosis.
-Tumor-related treatment in last 3 months (i.e. Chemotherapy, Radiotherapy, Immunotherapy, Hormone therapy treatment, Surgery etc.)
-History of taking any of the following drugs in last 08 week:
i. Corticosteroid containing drugs
ii. Immunosuppressants (Methotrexate, Cyclosporine, Azathioprine, Tacrolimus, Mycophenolate, Rapamycin, Sirolimus, Adalimumab, Infliximab etc.) :
iii. GMCSF (Sargramostim)
-History of severe febrile illness or inflammation during the last 8 weeks before blood draw
-History of Covid during the last 8 weeks
-History of any vaccination during preceding 4 weeks
-History of any surgery or severe trauma during last 8 weeks
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method